# Polymorphism at position –308 of the tumour necrosis factor α gene and rheumatoid arthritis pharmacogenetics

## Metadata
**Authors:** J Fonseca, T Carvalho, M Cruz, P Nero, M Sobral, A Mourao, J Cavaleiro, D Ligeiro, I Abreu, M Carmo-Fonseca, J Branco
**Journal:** Annals of the Rheumatic Diseases
**Date:** 2005 May
**DOI:** [10.1136/ard.2004.028167](https://doi.org/10.1136/ard.2004.028167)
**PMID:** 15834068
**PMCID:** PMC1755496
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755496/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC1755496/pdf/v064p00793.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC1755496/pdf/v064p00793.pdf)

## Full Text

The Full Text of this article is available as a [PDF](/articles/instance/1755496/pdf/v064p00793.pdf) (54.9 KB).

![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0bb/1755496/91676084e299/ar28167.f1.jpg)

Mean improvement in DAS28 with infliximab treatment between first administration and the evaluation performed before each subsequent treatment in seven patients with RA with the TNFα –308 genotype AG and 15 patients with RA with the TNFα –308 genotype GG. Bars represent standard deviation; *p<0.05.
